Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP): A Multicenter, Randomized, Placebo-controlled, Double Blind Study
Sponsor: Lahey Clinic
This NA trial investigates Progressive Supranuclear Palsy and is currently completed. Lahey Clinic leads this study, which shows 8 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Phase: PHASE2_PHASE3 → NA
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
First recorded
Sep 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lahey Clinic
For direct contact, visit the study record on ClinicalTrials.gov .